SYDNEY, Feb. 18 (Xinhua) -- A groundbreaking Australian clinical trial has shown that a majority of melanoma patients whose cancer has spread to the brain can be cured with combination immunotherapy.

New Delhi, February 18 (IANS): A combination immunotherapy may help cure a majority of patients with melanoma -- a deadly ...

the four-year survival rate for patients with Stage 4 uveal melanoma is only about 2 percent, according to one study. She had taken part in three clinical trials and received three additional ...

The current survival rates are highest for thyroid cancer, prostate cancer, testicular cancer, and melanoma. The survival rate for early-stage breast cancer is also high because of screening ...